Barcelona, Spain · Founded 2014 · Privately Held (backing)
Developer of cell-penetrating mini-protein therapeutics designed to treat cancer. Peptomyc is based in Barcelona, Spain and was founded in 2014. Its last reported valuation was $40.5 million in Dec 2020. It has raised $25 million.
Last reported valuation
$40.5M
Oct 2026
Priced at
—
Total raised
$25.0M
Last round
—
Cap table — not yet on record
Peptomyc's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Peptomyc with a free account
·The complete investor list: 20 names
·Watch Peptomyc: the Monday email on marks, rounds and moves
